| Title: |
Half-Year Longitudinal Seroprevalence of SARS-CoV-2-Antibodies and Rule Compliance in German Hospital Employees |
| Authors: |
Jonas Herzberg; Tanja Vollmer; Bastian Fischer; Heiko Becher; Ann-Kristin Becker; Hany Sahly; Human Honarpisheh; Salman Yousuf Guraya; Tim Strate; Cornelius Knabbe |
| Source: |
International Journal of Environmental Research and Public Health, Vol 18, Iss 10972, p 10972 (2021) |
| Publisher Information: |
MDPI AG |
| Publication Year: |
2021 |
| Collection: |
Directory of Open Access Journals: DOAJ Articles |
| Subject Terms: |
SARS-CoV-2 IgG antibody; health care worker; seroprevalence; COVID-19; health; Medicine |
| Description: |
COVID-19, which is caused by SARS-CoV-2, is an occupational health risk, especially for healthcare employees due to their higher exposure and consequently higher risk of symptomatic and asymptomatic infections. This study was designed to determine the longitudinal seroprevalence of specific immunoglobulin-G (IgG) antibodies in employees in a hospital setting. All employees in a secondary care hospital, including healthcare and non-healthcare workers, were invited to participate in this single-center study. After an initial screening, a 6-month follow-up was carried out, which included serological examination for SARS-CoV-2 IgG antibodies and a questionnaire for self-reported symptoms, self-perception, and thoughts about local and national hygiene and pandemic plans. The seroprevalence of SARS-CoV-2 IgG antibodies was 0.74% among 406 hospital employees (0.75% in healthcare workers, 0.72% in non-healthcare workers), initially recruited in April 2020, in their follow-up blood specimens in October 2020. In this study, 30.54% of the participants reported using the official German coronavirus mobile application and the majority were content with the local and national rules in relation to coronavirus-related restrictions. At the 6-month follow-up, the 0.74% seroprevalence was below the reported seroprevalence of 1.35% in the general German population. The prevalence in healthcare workers in direct patient care compared with that in workers without direct patient contact did not differ significantly. Further follow-up to monitor the seroprevalence in the high-risk healthcare sector during the ongoing global pandemic is essential. |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| Relation: |
https://www.mdpi.com/1660-4601/18/20/10972; https://doaj.org/toc/1661-7827; https://doaj.org/toc/1660-4601; https://doaj.org/article/2c620f797de44b84be317f51585a9feb |
| DOI: |
10.3390/ijerph182010972 |
| Availability: |
https://doi.org/10.3390/ijerph182010972; https://doaj.org/article/2c620f797de44b84be317f51585a9feb |
| Accession Number: |
edsbas.82B51703 |
| Database: |
BASE |